A new method and a new chemical therapy that is minimally invasive and avoids the complete exposure of the body to chemotherapeutic agents in the treatment of the most common forms of breast cancer was presented in the Oct. 4, 2013, issue of the Journal of Visualized Experiments by Dr. Silva Krause at Children's Hospital Boston and colleagues.
The revolutionary technique involves the injection of therapeutic agents through the nipple. This procedure provides direct access to the milk ducts where most forms of breast cancer develop.
The procedure targets the breast only and avoids the side effects that are associated with chemotherapy. Those side effects include fatigue, nausea, hair loss, anemia, and other potentially more serious problems.
The procedure utilizes a new nanoparticle-based therapeutic that has proven successful in the prevention of the activity of a gene that is known to drive breast tumor formation in mice. The testing in mice prevented the spontaneous development of mammary tumors.
While not ready for humans yet, this procedure offers a great hope for women who have breast tumors and breast cancer. There is also a huge preventative potential in the therapeutic agent based on mouse testing.
The sales slogan for the new therapeutic and the procedure may well be “You don’t have to lose your hair anymore if you have breast cancer.”
A video of the procedure is available here.